CO6531435A2 - Nuevas formulaciones de vacuna que comprende adyuvantes que contienen saponina - Google Patents
Nuevas formulaciones de vacuna que comprende adyuvantes que contienen saponinaInfo
- Publication number
- CO6531435A2 CO6531435A2 CO12058153A CO12058153A CO6531435A2 CO 6531435 A2 CO6531435 A2 CO 6531435A2 CO 12058153 A CO12058153 A CO 12058153A CO 12058153 A CO12058153 A CO 12058153A CO 6531435 A2 CO6531435 A2 CO 6531435A2
- Authority
- CO
- Colombia
- Prior art keywords
- saponina
- vaccine
- new formulations
- adjuvants containing
- emulsion
- Prior art date
Links
- 239000002671 adjuvant Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/135—Foot- and mouth-disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención proporciona una emulsión de aceite en agua (O/W) novedosa, con estabilidad incrementada en la presencia de suspensiones bacterianas o virales, especialmente aquellas concentradas y no purificadas (extractos crudos) o mínimamente purificadas. La emulsión de la presente invención puede actuar como vehículo para el suministro de una composición farmacéutica que comprende por lo menos un inmunógeno y, en particular, un inmunógeno seleccionado del grupo que consiste de un patógeno inactivado, un patógeno atenuado, una subunidad, un vector de expresión recombinante y un plásmido o combinaciones de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24117109P | 2009-09-10 | 2009-09-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6531435A2 true CO6531435A2 (es) | 2012-09-28 |
Family
ID=43063042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12058153A CO6531435A2 (es) | 2009-09-10 | 2012-04-10 | Nuevas formulaciones de vacuna que comprende adyuvantes que contienen saponina |
Country Status (26)
Country | Link |
---|---|
US (2) | US9107859B2 (es) |
EP (1) | EP2475384B1 (es) |
JP (1) | JP5759463B2 (es) |
KR (1) | KR101746880B1 (es) |
CN (2) | CN107213461B (es) |
AR (2) | AR078169A1 (es) |
AU (1) | AU2010292233B2 (es) |
CA (1) | CA2773486C (es) |
CO (1) | CO6531435A2 (es) |
CY (1) | CY1119052T1 (es) |
DK (1) | DK2475384T3 (es) |
ES (1) | ES2600929T3 (es) |
HR (1) | HRP20161414T1 (es) |
HU (1) | HUE030664T2 (es) |
LT (1) | LT2475384T (es) |
MX (2) | MX344863B (es) |
MY (1) | MY157607A (es) |
NZ (1) | NZ598645A (es) |
PL (1) | PL2475384T3 (es) |
PT (1) | PT2475384T (es) |
RU (1) | RU2555342C2 (es) |
SG (1) | SG179037A1 (es) |
SI (1) | SI2475384T1 (es) |
SM (1) | SMT201600394B (es) |
UA (1) | UA107940C2 (es) |
WO (1) | WO2011031850A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010251761B2 (en) * | 2009-05-19 | 2014-10-09 | Bioproperties Pty Ltd | A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof |
CN102648003B (zh) * | 2009-10-09 | 2016-01-13 | 儿童医疗中心有限公司 | 选择性裂解的全细胞疫苗 |
CN102226153B (zh) * | 2011-05-10 | 2012-12-05 | 黑龙江大学 | 用于生成污染菌抗血清的免疫原的制备方法 |
WO2013001034A1 (en) * | 2011-06-28 | 2013-01-03 | Leukocare Ag | Novel stabilisation method for viruses or bacteria |
AU2013221479B2 (en) | 2012-02-14 | 2017-06-08 | Boehringer Ingelheim Animal Health USA Inc. | Rotavirus subunit vaccines and methods of making and use thereof |
RU2521513C1 (ru) * | 2013-04-09 | 2014-06-27 | Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") | Применение этония в качестве адъюванта для производства сорбированной противоящурной вакцины |
US9649370B2 (en) | 2013-05-08 | 2017-05-16 | Protatek International, Inc. | Vaccine for PCV2 and mycoplasma |
US9713639B2 (en) | 2014-05-19 | 2017-07-25 | Merial, Inc. | Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV) |
CA2973828C (en) * | 2015-01-16 | 2023-09-19 | Zoetis Services Llc | Foot-and-mouth disease vaccine |
CN104803850A (zh) * | 2015-04-29 | 2015-07-29 | 天津大学 | 一种酯类糖基相选择性亲油凝胶因子及其制备方法以及在油品胶凝中的应用 |
KR20180021816A (ko) | 2015-06-26 | 2018-03-05 | 메리얼 인코포레이티드 | 불활성화된 개 인플루엔자 백신 및 이의 제조 방법 및 용도 |
MX2018004221A (es) | 2015-10-08 | 2019-11-08 | Pasteur Institut | Vacuna heterologa atenuada viva para leptospira. |
MA42640B1 (fr) | 2015-11-23 | 2021-06-30 | Merial Inc | Protéines de fusion de dmdv et e2 et leurs utilisations |
TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
WO2017176950A2 (en) | 2016-04-07 | 2017-10-12 | Merial, Inc. | Heartworm vaccine, methods and uses thereof |
JOP20190088A1 (ar) | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
PL3554536T3 (pl) | 2016-12-14 | 2023-03-06 | Boehringer Ingelheim Animal Health USA Inc. | Rekombinowane wektory hvt wyrażające wiele antygenów patogenów ptasich oraz szczepionki je zawierające |
WO2018222874A1 (en) | 2017-05-31 | 2018-12-06 | Texas Tech University System | Methods and devices for the treatment of food allergies |
CN109806391A (zh) * | 2017-11-22 | 2019-05-28 | 西北民族大学 | 一种兽用疫苗免疫水溶性复合佐剂的制备方法及其应用 |
CN108853493A (zh) * | 2018-07-26 | 2018-11-23 | 中国人民解放军陆军军医大学 | 麦冬皂苷d及其纳米乳在制备疫苗佐剂中的应用 |
CN111658611B (zh) * | 2020-04-13 | 2021-06-01 | 四川大学 | 一种基于微乳的疫苗递送系统及其制备方法和应用 |
BR102021012953A2 (pt) * | 2021-06-29 | 2023-01-10 | Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. | Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso |
US20230255886A1 (en) * | 2022-02-16 | 2023-08-17 | Chemical & Schutz High Performance Lubricants, S.A. De C.V. | Self-emulsionable mineral oil as a vehicle in vaccines for poultry |
CN116983396B (zh) * | 2023-08-09 | 2024-05-07 | 浙江省农业科学院 | 兔支气管败血波氏杆菌灭活疫苗乳剂及其制备和应用 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2777608A (en) | 1953-09-18 | 1957-01-15 | Sheffler James | Soap powder dispenser attachment |
GB1143545A (en) | 1965-03-25 | 1969-02-26 | Wellcome Found | Injectable vaccine emulsions |
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
CA1331443C (en) * | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
WO1991018627A1 (en) | 1990-05-29 | 1991-12-12 | Smithkline Beecham Corporation | Swine pneumonia vaccine and method for the preparation thereof |
DE69233158T2 (de) | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
DK0580778T3 (da) * | 1991-04-19 | 2000-01-31 | Lds Technologies Inc | Konvertible mikroemulsionsformuleringer |
US5846805A (en) | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
CA2085827C (en) * | 1991-12-23 | 2003-10-14 | Lucas A. T. Hilgers | Adjuvant composition containing synthetic hydrophobic lipopolysaccharide |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
CN1080300C (zh) | 1993-02-08 | 2002-03-06 | 美国拜尔公司 | 培养猪生殖和呼吸综合症病毒的方法及其在疫苗中的应用 |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
FR2723740B1 (fr) | 1994-08-16 | 1996-11-08 | Pasteur Merieux Serums Vacc | Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications |
AUPM873294A0 (en) * | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
US5997881A (en) | 1995-11-22 | 1999-12-07 | University Of Maryland, Baltimore | Method of making non-pyrogenic lipopolysaccharide or A |
US5866401A (en) | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
US5980912A (en) | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
ATE435661T1 (de) * | 1997-08-29 | 2009-07-15 | Antigenics Inc | Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel |
AU1145699A (en) * | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
KR100682154B1 (ko) | 1998-05-07 | 2007-02-12 | 코릭사 코포레이션 | 아쥬번트 조성물 및 그의 사용방법 |
TWI224107B (en) | 1998-10-22 | 2004-11-21 | Pfizer Prod Inc | Novel proteins from actinobacillus pleuropneumoniae |
CA2440933A1 (en) | 1998-12-22 | 2000-06-22 | Pfizer Products Inc. | An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
GB0009735D0 (en) | 2000-04-19 | 2000-06-07 | Zeneca Ltd | Formulation |
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
DE10113284A1 (de) | 2001-03-16 | 2002-10-02 | Heinrich Exner | Adjuvans-Emulsion und Verfahren zu deren Verwendung |
US7314624B2 (en) * | 2001-06-05 | 2008-01-01 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
US6642178B2 (en) | 2001-11-14 | 2003-11-04 | North Dakota State University | Adjuvant blend for enhancing efficacy of pesticides |
US7378101B2 (en) * | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
RU2354399C2 (ru) * | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
US7691368B2 (en) * | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
US20080226669A1 (en) * | 2005-12-29 | 2008-09-18 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
MX2009006469A (es) * | 2006-12-15 | 2009-06-26 | Schering Plough Ltd | Metodo de duplicacion del virus de la influenza en cultivo. |
-
2010
- 2010-09-09 WO PCT/US2010/048256 patent/WO2011031850A1/en active Application Filing
- 2010-09-09 MX MX2014013363A patent/MX344863B/es unknown
- 2010-09-09 MY MYPI2012001035A patent/MY157607A/en unknown
- 2010-09-09 NZ NZ598645A patent/NZ598645A/en unknown
- 2010-09-09 US US12/878,630 patent/US9107859B2/en active Active
- 2010-09-09 JP JP2012528894A patent/JP5759463B2/ja active Active
- 2010-09-09 SI SI201031314A patent/SI2475384T1/sl unknown
- 2010-09-09 EP EP10757885.8A patent/EP2475384B1/en active Active
- 2010-09-09 CA CA2773486A patent/CA2773486C/en active Active
- 2010-09-09 LT LTEP10757885.8T patent/LT2475384T/lt unknown
- 2010-09-09 PL PL10757885T patent/PL2475384T3/pl unknown
- 2010-09-09 CN CN201710382912.3A patent/CN107213461B/zh active Active
- 2010-09-09 RU RU2012113814/15A patent/RU2555342C2/ru active
- 2010-09-09 AU AU2010292233A patent/AU2010292233B2/en active Active
- 2010-09-09 KR KR1020127009114A patent/KR101746880B1/ko active IP Right Grant
- 2010-09-09 DK DK10757885.8T patent/DK2475384T3/en active
- 2010-09-09 SG SG2012016168A patent/SG179037A1/en unknown
- 2010-09-09 ES ES10757885.8T patent/ES2600929T3/es active Active
- 2010-09-09 HU HUE10757885A patent/HUE030664T2/en unknown
- 2010-09-09 MX MX2012002814A patent/MX2012002814A/es active IP Right Grant
- 2010-09-09 CN CN201080047645.0A patent/CN102573900B/zh active Active
- 2010-09-09 UA UAA201204469A patent/UA107940C2/ru unknown
- 2010-09-09 PT PT107578858T patent/PT2475384T/pt unknown
- 2010-09-10 AR ARP100103323A patent/AR078169A1/es not_active Application Discontinuation
-
2012
- 2012-04-10 CO CO12058153A patent/CO6531435A2/es unknown
-
2015
- 2015-02-26 US US14/632,863 patent/US9730987B2/en active Active
-
2016
- 2016-10-12 CY CY20161101013T patent/CY1119052T1/el unknown
- 2016-10-27 HR HRP20161414TT patent/HRP20161414T1/hr unknown
- 2016-11-03 SM SM201600394T patent/SMT201600394B/it unknown
-
2021
- 2021-01-21 AR ARP210100138A patent/AR121096A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6531435A2 (es) | Nuevas formulaciones de vacuna que comprende adyuvantes que contienen saponina | |
CL2018000740A1 (es) | Vectores del factor viii del virus adeno-asociado, partículas víricas asociadas y formulaciones terapéuticas que los comprenden | |
EP4233898A3 (en) | Influenza mrna vaccines | |
CL2017001191A1 (es) | Compuestos derivados de carbamoilpiridona policíclicos; composición farmacéutica que los comprende; y su uso para el tratamiento de una infección de vih en un humano que tiene o se encuentra en riesgo de tener la infección. | |
EP4104854A3 (en) | Multivalent vaccines for rabies virus and coronaviruses | |
CO2023001072A2 (es) | Vacuna combinada de sars-cov-2 e influenza | |
MA40765A (fr) | Méthodes et compositions d'induction d'une immunité protectrice contre l'infection par le virus de l'immunodéficience humaine | |
CO6290682A2 (es) | Compuestos triciclicos fusionados inhibidores del virus de la hepatitis c. | |
CU20170109A7 (es) | Derivado de quinoleina para tratar y prevenir infecciones virales | |
CL2017001961A1 (es) | Vacuna bivalente contra el virus de gripe porcina | |
AR061894A1 (es) | Vacunas para malaria | |
CO6290791A2 (es) | Vacunas y composiciones inmunogénicas que contienen nuevas cepas del circo virus porcino tipo 2b para inmunizar cerdos contra pmws | |
CO2021006308A2 (es) | Proteínas f de prefusión del vrs estabilizadas | |
PE20200336A1 (es) | Formulaciones a largo plazo | |
CO2019000214A2 (es) | Vacuna contra virus de bronquitis infecciosa | |
CO2018010874A2 (es) | Vacuna de virus de zika atenuado vivo | |
MX2017015462A (es) | Vectores atenuados de influenza para la prevencion y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncologicas. | |
BR112012021650A2 (pt) | "parvovírus recombinante atenuado, vacina para a proteção de animais contra infecção com parvovírus, método para a obtenção de um parvovírus recombinante, e, uso de uma vacina." | |
EA201390812A1 (ru) | Лиофилизированные вирусные составы | |
CO7461133A2 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
CO2017001614A2 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
AR101814A1 (es) | Partícula de tipo virus flavivirus | |
CO7461135A2 (es) | Parvovirus porcino 5b, métodos de uso y vacuna | |
MX347911B (es) | Vacuna contra virus de diarrea viral de bovinos. | |
NI201700080A (es) | Composiciones de vacuna para el virus del dengue y métodos de uso de las mismas. |